{"id":"https://openalex.org/W61411103","doi":"https://doi.org/10.1096/fasebj.21.6.a792-c","title":"In vivo analysis of brain AT1 angiotensin receptor signaling pathways","display_name":"In vivo analysis of brain AT1 angiotensin receptor signaling pathways","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W61411103","doi":"https://doi.org/10.1096/fasebj.21.6.a792-c","mag":"61411103"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.21.6.a792-c","doi":"https://doi.org/10.1096/fasebj.21.6.a792-c","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.21.6.a792-c","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037761449","display_name":"Vardan T. Karamyan","orcid":"https://orcid.org/0000-0003-0050-6047","observed_orcids":["https://orcid.org/0000-0003-0050-6047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vardan T. Karamyan","raw_affiliation_strings":["Pharmacology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025905944","display_name":"Robert Charles Speth","orcid":"https://orcid.org/0000-0002-6434-2136","observed_orcids":["https://orcid.org/0000-0002-6434-2136"]},"institutions":[{"id":"https://openalex.org/I368840534","display_name":"University of Mississippi","ror":"https://ror.org/02teq1165","country_code":"US","type":"education","lineage":["https://openalex.org/I368840534","https://openalex.org/I4210141039"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C Speth","raw_affiliation_strings":["Pharmacology","Research Institute of Pharmaceutical Sciences, University of Mississippi, School of Pharmacy, University, MS, 38677"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology","institution_ids":[]},{"raw_affiliation_string":"Research Institute of Pharmaceutical Sciences, University of Mississippi, School of Pharmacy, University, MS, 38677","institution_ids":["https://openalex.org/I368840534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01061648,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"6","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.9850000143051147},{"id":"https://openalex.org/keywords/brain","display_name":"brain","score":0.5569999814033508},{"id":"https://openalex.org/keywords/intracellular-signaling","display_name":"intracellular signaling","score":0.8479999899864197},{"id":"https://openalex.org/keywords/phospholipase-c","display_name":"phospholipase C","score":0.9279999732971191},{"id":"https://openalex.org/keywords/protein-kinase-c","display_name":"protein kinase C","score":0.9990000128746033},{"id":"https://openalex.org/keywords/map-kinase-cascade","display_name":"MAP kinase cascade","score":0.7820000052452087},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/pressor-response","display_name":"pressor response","score":0.7139999866485596},{"id":"https://openalex.org/keywords/dipsogenic-response","display_name":"dipsogenic response","score":0.8709999918937683},{"id":"https://openalex.org/keywords/water-intake","display_name":"water intake","score":0.7670000195503235},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6850000023841858},{"id":"https://openalex.org/keywords/chelerythrine","display_name":"chelerythrine","score":0.7839999794960022},{"id":"https://openalex.org/keywords/u-73122","display_name":"U73122","score":0.8830000162124634},{"id":"https://openalex.org/keywords/pd98059","display_name":"PD98059","score":0.9739999771118164}],"concepts":[{"id":"https://openalex.org/C2776108454","wikidata":"https://www.wikidata.org/wiki/Q5089853","display_name":"Chelerythrine","level":4,"score":0.7755597829818726},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.684280514717102},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6707011461257935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.63907790184021},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.585185170173645},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.5522635579109192},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5073613524436951},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4637361764907837},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4546504616737366},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.4451349675655365},{"id":"https://openalex.org/C2778597717","wikidata":"https://www.wikidata.org/wiki/Q420248","display_name":"Phospholipase C","level":3,"score":0.4430438280105591},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.4221609830856323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.344917356967926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33354389667510986},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.22702789306640625},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09943976998329163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.21.6.a792-c","doi":"https://doi.org/10.1096/fasebj.21.6.a792-c","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.21.6.a792-c","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2164232039","https://openalex.org/W1997057063","https://openalex.org/W1994003684","https://openalex.org/W1997993475","https://openalex.org/W2023402990","https://openalex.org/W2042225806","https://openalex.org/W1992231908","https://openalex.org/W2158454136","https://openalex.org/W2417035394","https://openalex.org/W2014178542"],"abstract_inverted_index":{"AT1":[0,23,200],"receptors":[1,24],"mediate":[2,220],"pressor":[3,154,210],"and":[4,31,72,211],"dipsogenic":[5,212,224],"actions":[6],"of":[7,21,74,102,198,205,226],"angiotensin":[8],"II":[9,48,82,104,128,153,168,185,228],"(Ang":[10],"II)":[11,170],"in":[12,25,66,78,229],"the":[13,94,100,126,151,183,191,195,206,216,230],"brain.":[14,231],"This":[15],"study":[16],"examined":[17],"intracellular":[18],"signaling":[19],"pathways":[20],"brain":[22,199],"vivo":[26],",":[27],"using":[28],"specific":[29],"inhibitors":[30],"Ang":[32,47,81,103,127,152,184,227],"II,":[33],"administered":[34],"intracerebroventricularly.":[35],"Vehicle":[36],"or":[37],"inhibitor":[38,123,148,171,181,208],"(2":[39,86],"\u03bcl)":[40],"was":[41],"given":[42],"15":[43],"min":[44],"prior":[45],"to":[46,54,80],"(100":[49,116],"pmol/2":[50],"\u03bcl":[51],"artificial":[52],"CSF)":[53],"adult,":[55],"male":[56],"Sprague\u2010Dawley":[57],"rats":[58],"implanted":[59],"with":[60],"radiotelemetric":[61],"blood":[62,69],"pressure":[63,70],"transducers.":[64],"Increases":[65],"mean":[67],"arterial":[68],"(BP)":[71],"volume":[73],"water":[75],"drunk":[76],"(WV)":[77],"response":[79],"were":[83],"monitored.":[84],"U\u201073122":[85],"nmol)":[87,139],"a":[88,118,164,177],"phospholipase":[89],"C":[90,121],"inhibitor,":[91],"but":[92,222],"not":[93,223],"inactive":[95],"analog":[96],"U\u201073433":[97],"(n=4),":[98],"attenuated":[99,149],"effects":[101,129,204,225],"(BP:":[105,130],"41.7":[106],"%;":[107,110],"WV:":[108,133],"56.5":[109],"p<0.05":[111,135,157],"n":[112],"=":[113],"6).":[114],"Chelerythrine":[115],"pmol)":[117],"protein":[119],"kinase":[120,142,143,146],"(PKC)":[122],"also":[124],"inhibited":[125],"20.1%":[131],"p<0.01;":[132],"37.5%":[134],"n=8).":[136],"PD\u201098059":[137],"(1":[138],"an":[140],"MAP":[141],"(MEK,":[144],"ERK/MAP":[145],"cascade)":[147],"only":[150],"effect":[155],"(28.2%":[156],"n=6).":[158],"Neither":[159],"KN\u201093":[160],"(40":[161,174],"pmol,":[162,175],"n=6)":[163],"Ca":[165],"2+":[166],"/Calmodulin\u2010kinase":[167],"(CaCMK":[169],"nor":[172],"wortmannin":[173],"n=5)":[176],"PI":[178],"3":[179],"\u2010kinase":[180],"affected":[182],"responses.":[186,201],"The":[187,202],"results":[188],"indicate":[189],"that":[190,215],"PLC/PKC":[192],"pathway":[193],"is":[194],"dominant":[196],"mediator":[197],"differential":[203],"MEK":[207],"on":[209],"responses":[213],"suggests":[214],"MAPK":[217],"cascade":[218],"may":[219],"pressor,":[221]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}